Philip Scheltens

机构：Development Fund, Amsterdam Neuroscience, Amsterdam University Medical Centers, Amsterdam University of Applied Sciences, Vrije Universiteit Amsterdam · ORCID：0000-0002-1046-6408

发表论文 2368 篇 · 总被引 194178 次 · h-index 181

代表论文

• Biomarker-guided decision making in clinical drug development for neurodegenerative disorders (2025 · Nature Reviews Drug Discovery · 被引 50)
• Brain health services for the secondary prevention of cognitive impairment and dementia: Opportunities, challenges, and the business case for existing and future facilities (2025 · The Journal of Prevention of Alzheimer s Disease · 被引 23)
• Transferability of European-derived Alzheimer’s disease polygenic risk scores across multiancestry populations (2025 · Nature Genetics · 被引 22)
• Machine learning in Alzheimer’s disease genetics (2025 · Nature Communications · 被引 17)
• Amyloid-Beta Pathology and Cognitive Performance in Centenarians (2025 · JAMA Neurology · 被引 16)
• Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled study (2025 · EBioMedicine · 被引 13)